SCreening adults with Obesity to Reduce Heart Failure Events

Recruiting

• Conditions: obesitas; heaviness; severe overweight; 10019280

• Registration Number: NL-OMON56190
• Lead Sponsor: Cardiologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 9 September 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 420

Inclusion Criteria

Age >=45 year, BMI >=30 kg/m2, and written informed consent.

Exclusion Criteria

Known cardiac disease (determined by assessment of the available patient files
and by asking the patient).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study endpoint is a combined endpoint of left ventricular dysfunction<br /><br>and/or HF admission. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>- Prevalence at baseline of not yet diagnosed HF as identified by active<br /><br>screening<br /><br>- Prevalence at baseline of undiscovered risk factors for HF (e.g.<br /><br>hypertension, diabetes) as identified by active screening<br /><br>- Risk factors for having HF in subjects with a HF diagnosis at baseline by<br /><br>active screening (e.g. age, sex, BMI, waist circumference, hypertension,<br /><br>diabetes)<br /><br>- Quality of life (EQ-5D-5L questionnaire) at 1 year follow-up in all subjects<br /><br>- Effect of HF treatment on dyspnea (NYHA classification) at 1 year follow-up<br /><br>in screened patients with HF at the time of screening</p><br>